SCHWARZ.
SCHWARZ.
  • D
  • Home
  • Focus
  • Clients
  • Profile
  • Values
  • Imprint
  • Privacy Policy
  • Contact
  • Newsfeed
SCHWARZ.
Small. Strong. Schwarz.
Financial Communication
  • D
  • Home
  • Focus
  • Clients
  • Profile
  • Values
  • Imprint
  • Privacy Policy
Made with Passion and Coffee
in Wiesbaden

Dr. Daniel Vitt, Ph.D., joined @ImmunicInc in January 2017. Previously, he was Chief Scientific Officer and Chief Development Officer of 4SC AG, a publicly traded company that he co-founded in 1997.

e-Meet Daniel at #Sachs_EHTF

More info @ https://t.co/HI7OAD4QYO pic.twitter.com/Lp24mx6uCk

— Sachs Associates (@SachsAssociates) January 13, 2021
Contact
Newsfeed
@SachsAssociates
1. Feb 2023 via Twitter
Meet IAMA Therapeutics at #Sachs_ELSFMore info @ https://t.co/hgPC4hy6UF#Sachs_ELSF #SSLSW #lifescie…
@SachsAssociates
1. Feb 2023 via Twitter
Atriva is a mid-stage clinical development company with first-in-class host-targeting therapies to t…
@SachsAssociates
1. Feb 2023 via Twitter
Meet Relief Therapeutics at #Sachs_ELSFMore info @ https://t.co/hgPC4hy6UF#Sachs_ELSF #SSLSW #lifesc…